Stilbenes
Number of EDCs: 15
Chemical nameChemical identifierLiterature identifier
Clomiphene citrateDED000352PMID:15162385, PMID:6458924
2,2-Dimethoxy-2-phenylacetophenoneDED000388PMID:26692070
2,3-Bis(4-hydroxyphenyl)-propionitrileDED000398PMID:15635152, PMID:21554883
1,2-Diphenylcyclobutane, cis-DED000412PMID:11485868
ResveratrolDED000448PMID:18634814, PMID:19371625, PMID:28668442
HydroxytamoxifenDED000450PMID:15315699
Tamoxifen citrateDED000464PMID:15162385
TamoxifenDED000465PMID:11961216, PMID:12383709, PMID:12927363, PMID:15470002, PMID:24769059, PMID:25584031, PMID:26304810, PMID:27395752, PMID:28827578
EpoxiconazoleDED000479PMID:17785682, PMID:18067565, PMID:20708073, PMID:22140080, PMID:34182286, PMID:38499550
Amsonic acidDED000494PMID:1316972
1,2-Diphenylcyclobutane, trans-DED000532PMID:11485868
DiethylstilbestrolDED000665PMID:10210696, PMID:10377036, PMID:10397250, PMID:10641015, PMID:10908838, PMID:11229807, PMID:11961216, PMID:12446607, PMID:12520077, PMID:12589653, PMID:12858341, PMID:14636701, PMID:14695980, PMID:14711791, PMID:14746342, PMID:15016594, PMID:15019959, PMID:15162385, PMID:15166399, PMID:15219628, PMID:15315699, PMID:1537323, PMID:15470002, PMID:15596228, PMID:15597897, PMID:15751030, PMID:16439099, PMID:16723702, PMID:16759992, PMID:16819149, PMID:17010207, PMID:17011747, PMID:17184923, PMID:17213693, PMID:17229994, PMID:17394237, PMID:17558187, PMID:17679765, PMID:18296022, PMID:18692564, PMID:18769493, PMID:19299448, PMID:19734697, PMID:19887736, PMID:20046027, PMID:20172022, PMID:20433902, PMID:20815788, PMID:20932895, PMID:21130156, PMID:21761357, PMID:22569274, PMID:22679223, PMID:22710028, PMID:23314658, PMID:23454116, PMID:23873838, PMID:24002655, PMID:24316331, PMID:24449359, PMID:24533973, PMID:24578295, PMID:24646703, PMID:25062584, PMID:25242112, PMID:25243144, PMID:25852458, PMID:26349937, PMID:26457333, PMID:26970683, PMID:27103539, PMID:27613106, PMID:28031325, PMID:28078498, PMID:28265775, PMID:28734970, PMID:28970132, PMID:29102757, PMID:29752986, PMID:29931162, PMID:30153466, PMID:31084616, PMID:31283846, PMID:31780364, PMID:32370801, PMID:32545544, PMID:32592162, PMID:33012732, PMID:33571642, PMID:33920546, PMID:34207679, PMID:34831106, PMID:35605701, PMID:35834052, PMID:36096261, PMID:36328762, PMID:36488194, PMID:36621641, PMID:36653537, PMID:37077353, PMID:37268149, PMID:37471692, PMID:37511399, PMID:37561284, PMID:37650943, PMID:37689587, PMID:37779174, PMID:37854179, PMID:37856394, PMID:39326550, PMID:39730480, PMID:846001, PMID:9472934
Decabromodiphenyl ethaneDED000683PMID:29409581, PMID:30844666
DienestrolDED000768PMID:30986439, PMID:32171874
CyflumetofenDED001006PMID:36933840
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.